BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38280958)

  • 1. Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough?
    Liu EH
    Ann Surg Oncol; 2024 May; 31(5):2809-2810. PubMed ID: 38280958
    [No Abstract]   [Full Text] [Related]  

  • 2. What Is the Role of Lymph Node Resections in Small Islet Tumors?
    Gangi A; Ferrone CR
    Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Trends in the Number of Lymph Nodes Evaluated Following Resection of Pancreatic Neuroendocrine Tumors-An Increasing Adoption of the AJCC Guidelines?
    Sahara K; Tsilimigras DI; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1213-1214. PubMed ID: 31832917
    [No Abstract]   [Full Text] [Related]  

  • 4. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
    Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
    Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
    Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
    Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
    Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
    Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
    Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
    Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor.
    Takagi K; Umeda Y; Yoshida R; Yoshida K; Fuji T; Kumano K; Yasui K; Yagi T; Fujiwara T
    Anticancer Res; 2022 May; 42(5):2797-2801. PubMed ID: 35489738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
    Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
    Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
    Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
    Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
    Curran T; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
    J Gastrointest Surg; 2015 Jan; 19(1):152-60; discussion 160. PubMed ID: 25118642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
    Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
    J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter data.
    Wei G; Feng X; Wang W; Zhang Y; Zeng Y; Chen M; Chen Y; Chen J; Zhou Z; Li Y
    Future Oncol; 2018 Aug; 14(18):1817-1823. PubMed ID: 30019936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.